Corrigendum to “DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling” [Biochem. Biophys. Res. Commun. 450(1) (2014) 899–905] (Biochemical and Biophysical Research Communications (2014) 450(1) (899–905), (S0006291X14011504), (10.1016/j.bbrc.2014.06.076));DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 899-905

  Yang, Yi ^a,b   Liu, Lei ^a,b   Cai, Junchao ^a,b   Wu, Jueheng ^a,b   Guan, Hongyu ^c   Zhu, Xun ^a,b   Yuan, Jie ^a,b   Li, Mengfeng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

DEPDC1B; Invasion; Migration; Non small cell lung cancer; Wnt catenin

Indexed keywords

BETA CATENIN; DEPDC1B PROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL ACTIVATION; CELL FRACTIONATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION; WNT SIGNALING PATHWAY;

DEPDC1B; INVASION; MIGRATION; NON-SMALL CELL LUNG CANCER; WNT/Β-CATENIN;

CARCINOMA, NON-SMALL-CELL LUNG; CATENINS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84907197129     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2021.07.010     Document Type: Erratum

References (36)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
3. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N. Engl. J. Med. 350 2004 379 392
4. C.M. Lovly, and D.P. Carbone Lung cancer in 2010: one size does not fit all Nat. Rev. Clin. Oncol. 8 2011 68 70
5. C.L. Chaffer, and R.A. Weinberg A perspective on cancer cell metastasis Science 331 2011 1559 1564
6. B. Passlick, J.R. Izbicki, B. Kubuschok, W. Nathrath, O. Thetter, U. Pichlmeier, L. Schweiberer, G. Riethmuller, and K. Pantel Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer J. Clin. Oncol. 12 1994 1827 1832
7. R. Rosell, E. Felip, J. Maestre, J.M. Sanchez, J.J. Sanchez, J.L. Manzano, J. Astudillo, M. Taron, and M. Monzo The role of chemotherapy in early non-small-cell lung cancer management Lung Cancer 34 Suppl. 3 2001 S63 S74
8. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
9. J.P. Sleeman, and J.P. Thiery SnapShot: the epithelial-mesenchymal transition Cell 145 2011 162.e1
10. T. Valenta, G. Hausmann, and K. Basler The many faces and functions of beta-catenin EMBO J. 31 2012 2714 2736
11. Y. Fu, S. Zheng, N. An, T. Athanasopoulos, L. Popplewell, A. Liang, K. Li, C. Hu, and Y. Zhu Beta-catenin as a potential key target for tumor suppression Int. J. Cancer 129 2011 1541 1551
12. K. Willert, and K.A. Jones Wnt signaling: is the party in the nucleus? Genes Dev. 20 2006 1394 1404
13. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
14. G. Akiri, M.M. Cherian, S. Vijayakumar, G. Liu, A. Bafico, and S.A. Aaronson Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma Oncogene 28 2009 2163 2172
15. D.X. Nguyen, A.C. Chiang, X.H. Zhang, J.Y. Kim, M.G. Kris, M. Ladanyi, W.L. Gerald, and J. Massague WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis Cell 138 2009 51 62
16. J. Mazieres, B. He, L. You, Z. Xu, and D.M. Jablons Wnt signaling in lung cancer Cancer Lett. 222 2005 1 10
17. L. Ibrahim, M. Dominguez, and M. Yacoub Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus Immunology 79 1993 119 124
18. W. Chi, P. Yang, B. Li, C. Wu, H. Jin, X. Zhu, L. Chen, H. Zhou, X. Huang, and A. Kijlstra IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease J. Allergy Clin. Immunol. 119 2007 1218 1224
19. M.H. Ng, T.H. Ho, K.H. Kok, K.L. Siu, J. Li, and D.Y. Jin MIP-T3 is a negative regulator of innate type I IFN response J. Immunol. 187 2011 6473 6482
20. J. Li, H. Zhang, J. Wu, H. Guan, J. Yuan, Z. Huang, and M. Li Prognostic significance of integrin-linked kinase 1 overexpression in astrocytoma Int. J. Cancer 126 2010 1436 1444
21. J. Cai, H. Guan, L. Fang, Y. Yang, X. Zhu, J. Yuan, J. Wu, and M. Li MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis J. Clin. Invest. 123 2013 566 579
22. Y. Yang, L. Liu, Y. Zhang, H. Guan, J. Wu, X. Zhu, J. Yuan, and M. Li MiR-503 targets PI3K p85 and IKK-beta and suppresses progression of non-small cell lung cancer Int. J. Cancer. 2014 10.1002/ijc.28799
23. Z. Yuan, R. Wang, Y. Lee, C.Y. Chen, X. Yu, Z. Wu, D. Huang, L. Shen, and Z.W. Chen Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vgamma2Vdelta2 T cells J. Immunol. 182 2009 811 819
24. J. Wang, S. Wu, X. Jin, M. Li, S. Chen, J.L. Teeling, V.H. Perry, and J. Gu Retinoic acid-inducible gene-I mediates late phase induction of TNF-alpha by lipopolysaccharide J. Immunol. 180 2008 8011 8019
25. Y. Yang, J. Wu, H. Guan, J. Cai, L. Fang, J. Li, and M. Li MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2 FEBS Lett. 586 2012 3608 3612
26. A. Niida, T. Hiroko, M. Kasai, Y. Furukawa, Y. Nakamura, Y. Suzuki, S. Sugano, and T. Akiyama DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway Oncogene 23 2004 8520 8526
27. B. Lustig, B. Jerchow, M. Sachs, S. Weiler, T. Pietsch, U. Karsten, M. van de Wetering, H. Clevers, P.M. Schlag, W. Birchmeier, and J. Behrens Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors Mol. Cell. Biol. 22 2002 1184 1193
28. H.C. Crawford, B.M. Fingleton, L.A. Rudolph-Owen, K.J. Goss, B. Rubinfeld, P. Polakis, and L.M. Matrisian The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors Oncogene 18 1999 2883 2891
29. B. Wu, S.P. Crampton, and C.C. Hughes Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration Immunity 26 2007 227 239
30. T.J. Van Raay, K.B. Moore, I. Iordanova, M. Steele, M. Jamrich, W.A. Harris, and M.L. Vetter Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina Neuron 46 2005 23 36
31. H.E. Boudreau, C.G. Broustas, P.C. Gokhale, D. Kumar, R.R. Mewani, J.D. Rone, B.R. Haddad, and U. Kasid Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation Int. J. Mol. Med. 19 2007 29 39
32. B. Westhoff, I.N. Colaluca, G. D'Ario, M. Donzelli, D. Tosoni, S. Volorio, G. Pelosi, L. Spaggiari, G. Mazzarol, G. Viale, S. Pece, and P.P. Di Fiore Alterations of the Notch pathway in lung cancer Proc. Natl. Acad. Sci. U.S.A. 106 2009 22293 22298
33. F. Cappuzzo, E. Magrini, G.L. Ceresoli, S. Bartolini, E. Rossi, V. Ludovini, V. Gregorc, C. Ligorio, A. Cancellieri, S. Damiani, A. Spreafico, C.T. Paties, L. Lombardo, C. Calandri, G. Bellezza, M. Tonato, and L. Crino Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer J. Natl. Cancer. Inst. 96 2004 1133 1141
34. M. Miyaki, T. Iijima, J. Kimura, M. Yasuno, T. Mori, Y. Hayashi, M. Koike, N. Shitara, T. Iwama, and T. Kuroki Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer Cancer Res. 59 1999 4506 4509
35. W.M. Clements, J. Wang, A. Sarnaik, O.J. Kim, J. MacDonald, C. Fenoglio-Preiser, J. Groden, and A.M. Lowy Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer Cancer Res. 62 2002 3503 3506
36. P.P. Massion, W.L. Kuo, D. Stokoe, A.B. Olshen, P.A. Treseler, K. Chin, C. Chen, D. Polikoff, A.N. Jain, D. Pinkel, D.G. Albertson, D.M. Jablons, and J.W. Gray Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway Cancer Res. 62 2002 3636 3640